Yong Cheng

7.1k total citations · 1 hit paper
200 papers, 5.1k citations indexed

About

Yong Cheng is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biological Psychiatry. According to data from OpenAlex, Yong Cheng has authored 200 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 41 papers in Cellular and Molecular Neuroscience and 27 papers in Biological Psychiatry. Recurrent topics in Yong Cheng's work include Tryptophan and brain disorders (27 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers) and Retinal Diseases and Treatments (18 papers). Yong Cheng is often cited by papers focused on Tryptophan and brain disorders (27 papers), Neuroinflammation and Neurodegeneration Mechanisms (19 papers) and Retinal Diseases and Treatments (18 papers). Yong Cheng collaborates with scholars based in China, United States and Hong Kong. Yong Cheng's co-authors include Xiao‐Yan Qin, Qing‐Shan Liu, Y. Peng Loh, Chang Cao, Yang Du, Ze‐Xu Wei, Shuping Zhang, Xiaowan Li, Yang Hu and Long‐Chuan Yu and has published in prestigious journals such as Environmental Science & Technology, PLoS ONE and NeuroImage.

In The Last Decade

Yong Cheng

188 papers receiving 5.0k citations

Hit Papers

Aberrations in Peripheral Inflammatory Cytokine Levels in... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yong Cheng China 38 1.8k 841 840 805 738 200 5.1k
Yan Wu China 40 1.9k 1.1× 1.2k 1.4× 391 0.5× 1.1k 1.4× 963 1.3× 170 5.5k
Yan Leng China 42 3.8k 2.1× 1.1k 1.3× 880 1.0× 645 0.8× 713 1.0× 116 6.8k
Mohamed R. Mughal United States 36 1.7k 0.9× 813 1.0× 318 0.4× 1.2k 1.5× 1.3k 1.7× 54 5.0k
Ming Lu China 42 2.6k 1.4× 942 1.1× 920 1.1× 1.2k 1.5× 1.2k 1.6× 136 6.5k
Ertuğrul Kılıç Türkiye 46 2.3k 1.3× 1.1k 1.3× 477 0.6× 1.6k 2.0× 849 1.2× 163 6.3k
Marcello D’Amelio Italy 39 1.9k 1.0× 1.2k 1.5× 407 0.5× 737 0.9× 1.4k 1.8× 90 4.7k
Tao Lu China 27 3.4k 1.9× 928 1.1× 427 0.5× 819 1.0× 2.1k 2.8× 111 7.3k
Krishnan M. Dhandapani United States 44 2.4k 1.3× 793 0.9× 1.5k 1.8× 1.2k 1.5× 579 0.8× 111 6.1k
David T. Yew Hong Kong 43 1.8k 1.0× 1.3k 1.6× 314 0.4× 772 1.0× 969 1.3× 265 6.0k

Countries citing papers authored by Yong Cheng

Since Specialization
Citations

This map shows the geographic impact of Yong Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Cheng more than expected).

Fields of papers citing papers by Yong Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Cheng. The network helps show where Yong Cheng may publish in the future.

Co-authorship network of co-authors of Yong Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Cheng. A scholar is included among the top collaborators of Yong Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Cheng. Yong Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Liming, Mei Guo, Yang Du, et al.. (2025). Neurotrophic factor-α1/carboxypeptidase E controls progression and reversal of Alzheimer's disease pathogenesis in mice. Theranostics. 15(6). 2279–2292. 4 indexed citations
2.
Chen, Lei, Yong Shao, Ji Geng, et al.. (2025). Dual Role of Exosomes in Parkinson's Disease: Adenine Exerts a Beneficial Effect. CNS Neuroscience & Therapeutics. 31(4). e70331–e70331.
4.
Wang, Yanli, Lei Chen, Xiaolin Zhong, et al.. (2025). Antidepressant effects of ershiwei roudoukou pills and its active ingredient Macelignan: Multiple mechanisms involving oxidative stress, neuroinflammation and synaptic plasticity. Translational Psychiatry. 15(1). 163–163. 2 indexed citations
5.
Fu, Qiang, Rui Qiu, Jiaquan Liang, et al.. (2025). Sugemule-7 alleviates oxidative stress, neuroinflammation, and cell death, promoting synaptic plasticity recovery in mice with postpartum depression. Scientific Reports. 15(1). 1426–1426. 2 indexed citations
6.
Liu, Hua, et al.. (2025). Exosome derived from bone marrow derived mesenchymal stem cells prevents LPS-induced depressive like behaviors. Brain Research Bulletin. 231. 111527–111527.
7.
Fu, Qiang, Rui Qiu, Li Shang, et al.. (2025). ECHS1: pathogenic mechanisms, experimental models, and emerging therapeutic strategies. Orphanet Journal of Rare Diseases. 20(1). 430–430. 1 indexed citations
8.
Chen, Lei, et al.. (2024). MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder. Molecular Neurobiology. 62(4). 5039–5056. 7 indexed citations
10.
Fu, Qiang, et al.. (2024). MicroRNAs: pioneering regulators in Alzheimer’s disease pathogenesis, diagnosis, and therapy. Translational Psychiatry. 14(1). 367–367. 41 indexed citations
11.
Du, Yang, et al.. (2023). Anti-depression-like effect of Mogroside V is related to the inhibition of inflammatory and oxidative stress pathways. European Journal of Pharmacology. 955. 175828–175828. 24 indexed citations
12.
Li, Yongbiao, et al.. (2023). The efficacy and safety of post-stroke cognitive impairment therapies: an umbrella review. Frontiers in Pharmacology. 14. 1207075–1207075. 15 indexed citations
13.
Shi, Xiaojie, Yang Du, Lei Chen, et al.. (2023). Treatment of polycystic ovary syndrome and its associated psychiatric symptoms with the Mongolian medicine Nuangong Qiwei Pill and macelignan. Journal of Ethnopharmacology. 317. 116812–116812. 5 indexed citations
14.
Du, Yang, et al.. (2023). Carboxypeptidase E conditional knockout mice exhibit learning and memory deficits and neurodegeneration. Translational Psychiatry. 13(1). 135–135. 8 indexed citations
15.
Zhang, Jingdan, Shuhan Liu, Xiaoheng Li, et al.. (2023). Bergapten alleviates depression-like behavior by inhibiting cyclooxygenase 2 activity and NF-κB/MAPK signaling pathway in microglia. Experimental Neurology. 365. 114426–114426. 17 indexed citations
16.
Du, Yang, et al.. (2023). Metabolomic and Proteomic Identification of Serum Exosome for Hypoxic Preconditioning Participants. Oxidative Medicine and Cellular Longevity. 2023. 1–10. 2 indexed citations
17.
Wang, Yanli, Yang Du, Lei Chen, Qing‐Shan Liu, & Yong Cheng. (2023). Fibroblast Growth Factor 2 Levels in Patients with Major Depressive Disorder: A Meta-analysis. Journal of Molecular Neuroscience. 73(2-3). 95–103.
18.
Chen, Jing, et al.. (2022). Muscone with Attenuation of Neuroinflammation and Oxidative Stress Exerts Antidepressant‐Like Effect in Mouse Model of Chronic Restraint Stress. Oxidative Medicine and Cellular Longevity. 2022(1). 3322535–3322535. 21 indexed citations
19.
Ye, Bo, Jian Feng, Yu Yang, et al.. (2013). Genetic Variant of Single-Nucleotide Polymorphism Is Associated with Risk of Esophageal Squamous Cell Carcinoma. Genetic Testing and Molecular Biomarkers. 18(1). 45–49. 8 indexed citations
20.
Jiang, Mali, Zhong Pei, Yong Cheng, et al.. (2010). Baicalein reduces E46K α‐synuclein aggregation in vitro and protects cells against E46K α‐synuclein toxicity in cell models of familiar Parkinsonism. Journal of Neurochemistry. 114(2). 419–429. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026